Tech Company Financing Transactions
Rivermark Medical Funding Round
Rivermark Medical secured a $30 million Series C funding round on 10/10/2024. Investors included American Century Investment Services, Cadence Healthcare Ventures and Time BioVentures.
Transaction Overview
Company Name
Announced On
10/10/2024
Transaction Type
Venture Equity
Amount
$30,000,000
Round
Series C
Investors
Proceeds Purpose
The company intends to use the funds to advance the clinical development of its flagship product, the FloStent� System, designed to restore urinary function for BPH patients.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
758 North Broadway 234
Milwaukee, WI 53202
USA
Milwaukee, WI 53202
USA
Phone
Undisclosed
Website
Email Address
Overview
Developing a minimally-invasive treatment for Benign Prostatic Hyperplasia (BPH) that rapidly restores urinary function and allows patients an early return to normal, daily life.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Andy Doraiswamy
Chief Executive Officer
Adam Kadlec
VP - Engineering
Andy Schieber
Browse more venture capital transactions:
Prev: 10/10/2024: Covu venture capital transaction
Next: 10/10/2024: CytoVale venture capital transaction
Share this article
About Database of VC Transactions
We do our best to document every notable VC transaction. VC investment data records on this site are derived from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs